BrainStorm Cell Therapeutics
BCLI
#10401
Rank
ยฃ4.97 M
Marketcap
ยฃ0.45
Share price
0.00%
Change (1 day)
-63.64%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Cash on Hand

Cash on Hand as of June 2025 : ยฃ0.61 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company has ยฃ0.61 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

BrainStorm Cell Therapeutics - Cash on Hand chart (from 2002 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31ยฃ0.14 M-85.4%
2023-12-31ยฃ1.02 M-58.62%
2022-12-31ยฃ2.46 M-84.94%
2021-12-31ยฃ16.36 M-46.8%
2020-12-31ยฃ30.76 M6990.24%
2019-12-31ยฃ0.43 M-92.2%
2018-12-31ยฃ5.56 M-3.03%
2017-12-31ยฃ5.73 M-29.12%
2016-12-31ยฃ8.09 M-24.8%
2015-12-31ยฃ10.76 M96.26%
2014-12-31ยฃ5.48 M158.32%
2013-12-31ยฃ2.12 M-15.99%
2012-12-31ยฃ2.52 M104.33%
2011-12-31ยฃ1.23 M1953.67%
2010-12-31ยฃ0.06 M9648.77%
2009-12-31ยฃ0 M-54.71%
2008-12-31ยฃ0 M-96.85%
2007-12-31ยฃ0.04 M41.32%
2006-12-31ยฃ0.03 M
2006-03-31ยฃ0.16 M-39.91%
2005-03-31ยฃ0.27 M11168.61%
2004-03-31ยฃ0 M-60.89%
2003-03-31ยฃ0 M-75%
2002-03-31ยฃ0.02 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Gilead Sciences
GILD
ยฃ5.51 B 891,768.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
ยฃ0.72 B 116,712.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
ยฃ0.92 B 150,020.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ2.97 B 480,531.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
ยฃ2.59 M 319.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA